Calmodulin-Cardiac Troponin C Chimeras

Total Page:16

File Type:pdf, Size:1020Kb

Calmodulin-Cardiac Troponin C Chimeras THEJOURNAL OF BIOLOGICALCHEMISTRY VOl. 268, No. 33, Issue of November 25, pp. 25213-252‘20.1993 0 1993 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.SA. Calmodulin-Cardiac TroponinC Chimeras EFFECTS OF DOMAIN EXCHANGE ON CALCIUM BINDING AND ENZYME ACTIVATION* (Received for publication, April 1, 1993, and in revised form, July 14, 1993) Samuel E. George$, ZenghuaSu, Daju Fan, and AnthonyR. Means From the Departments of Medicine and Pharmacology, Duke University Medical Center, Durham, North Carolina 27710 Calmodulin (CaM) and the cardiac isoform of tro- tant to understanding how CaM accomplishes its diverse ponin C (cTnC) are close structural homologs,but cTnC regulatory functions. cannot activate most CaM target enzymes. To investi- CaM is a 16.8-kDa protein that has four helix-loop-helix gate structure-function relationships, we constructed Ca2+binding domains, termed EF-hands. Thesedomains are a series of CaM-cTnC chimeras and determined their pairedin amino- and carboxyl-terminal globular domains, ability to bind Ca2+ andactivate CaM target enzymes. separated by a flexible 8-turn central helix (2-5). Upon com- Previously, we exchanged domain1 and found that the plex formation with model binding peptides, CaM undergoes chimeras exhibited profoundly impairedactivation of a striking structural rearrangement (6, 7). The central helix smooth muscle myosin light chain kinase (smMLCK) bends 100” and twists 120”, closely associating the two glob- and had differential effects on other CaM target en- ular Ca2+binding regions about a pseudo-2-fold axis of sym- zymes (George, s. E., VanBerkum, M. F. A., Ono, T., Downloaded from Cook, R., Hanley, R. M., Putkey, J. A., and Means,A. metry and enveloping the CaM-binding peptide in a hydro- R. (1990) J. Biol. Chern. 265,9228-9235). One of the phobic tunnel. The surface of the complex is composed pri- domain 1 chimeras was a potent competitive inhibitor marily of residues from the eight helical segments and the of smMLCK. We now extend our study of CaM-cTnC interhelix linker regions. The CaM-peptide complex structure chimeras by exchangingall of the remaining functionaldoes not reveal how the surface of CaM might interact with domains of CaM and cTnC. We determined the ability other functional domains of the CaM target enzyme. of the chimeras to bind Ca2+ and activate phosphodi- Chimeras between CaM and a homologous calcium-binding www.jbc.org esterase (PDE)and smMLCK.Chimeras containing protein, cardiac troponin C (cTnC), may help to define CaM- both domains 3 and 4 of cTnC exhibited high affinity target enzyme interactions. The two proteins show remarka- Caz+ binding that was indistinguishable from cTnC, ble structural similarity, with 50% amino acid identity (2, 8, whereas chimeras containing either domain 3 or 4 of 9). Although cTnC has not been crystallized, it has a high by guest, on January 15, 2010 cTnC demonstrated Ca2+affinity that was intermedi- degree of sequence similarity with both CaM and theskeletal ate between CaM andcTnC. All of the CaMOcTnC isoform of TnC (sTnC)(10). Therefore, it is likely that cTnC chimeras showed near-maximal PDE activation but shares thedumbbell-shaped structure described for CaM and required 5-775-fold higher concentrations thanCaM sTnC (2, 8, 9). to produce half-maximal PDE activation. In contrast, Despite its structural similarity to CaM, cTnC cannot ac- all of the chimeras showed impairedability to activate tivate CaM target enzymes (11,12). By exchanging functional smMLCK, and somewere potent competitive inhibitorsdomains between the two, it should be possible to define of smMLCK activation by CaM. regions of CaM that are essential for activation and cannot be substituted by corresponding domain of the inactive hom- olog, cTnC. The same approach may also be used to investi- gate other functional differences between CaM and cTnC, Calmodulin (CaM)’ is a ubiquitous intracellular Ca2+recep- such as the higher Ca2+affinity of cTnC’s carboxyl-terminal tor in eukaryotic cells. It participates in a number of intra- domains (13-15). The information gained from a CaM. cTnC cellular Ca2+signal transduction pathways through its ability chimera study can then direct a more detailed mutagenesis to bind and activate a number of regulatory proteins and study. enzymes (reviewed in Ref. 1).Understanding the structural We used this approach to show that substitution of CaM’s basis of CaM’s interaction with its target enzymes is impor- domain I had differentialeffects on CaM target enzymes (11). *This work was supported by grants from the American Heart One CaM .cTnC chimera, TaM-BM1 (domain 1 of cTnC, Association, Texas affiliate, the MethodistHospital Foundation, domains 2-4 of CaM, with its inactive first domain restored Houston, Texas (to S. E. G.), and Public Health Service Grant GM- by mutagenesis)activated some CaM target enzymes but 33976 (to A. R. M.). The costs of publication of this article were proved to be apotent competitive antagonistof smooth muscle defrayed in part by the payment of page charges. This article must myosin light chain kinase (smMLCK) (11).The competitive therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. inhibitor phenotype and additional data demonstrated that $Supported by a clinical investigator award from the National TaM-BM1 bound to smMLCK but failed to activate the Heart, Lung, and Blood Institute. To whom correspondence should enzyme. Further mutagenesis defined three residues in do- be addressed: Cardiovascular Division, Box 3060, Duke University main l of CaM that were essential for full activation of Medical Center, Durham, NC 27710. Tel.: 919-681-8446; Fax: 919- smMLCK, namely Glu-14, Thr-34, and Ser-38 (16). When 684-8591. these three CaM residues were mutated together,the resulting The abbreviations used are: CaM, calmodulin; MOPS, 3-(N- morpho1ino)propanesulfonicacid; DTT, dithiothreitol; PCR, polym- CaM triple mutant (E14A,T34K,S38M) reproduced the com- erase chain reaction; cTnC, cardiac troponin C; PDE, calmodulin- petitive inhibitor phenotypeof TaM-BM1. stimulated cyclic nucleotide phosphodiesterase; smMLCK, smooth Here we extend our approach to the remaining functional muscle myosin light chain kinase; bp, base pair(s). domains of CaM. We construct and assay a new series of 25213 25214 Calmodulin- TroponinC Chimeras CaM .cTnC chimeras, exchanging calcium binding domains pCaM[SacI] with NcoI and SUI. The resulting protein product con- 2, 3, and 4 and the central helices. Again we observe that tains amino acid residues 1-47 of CaM, 56-93 of cTnC, and 81-148 domain exchange has differential effects on target enzymes of CaM. and thatsome chimeras competitively inhibit CaM activation pTnCf.2 CUM/-The expression plasmid pTaM encodes a CaM. of smMLCK. cTnC chimera in which amino acid residues 1-56 (domain 1) are derived from cTnC and 57-157 correspond to 48-148 (domains 2-4) of CaM (11).We used PCR to amplify domains 1 and 2 of pTaM, EXPERIMENTALPROCEDURES designing the reverse oligo to incorporate a SacI site at nucleotides 276-281. This PCR product is treated with proteinase K (20), agarose Construction of Chimeras gel-purified, digested with NcoI and Sad, andsubcloned into avector To exchange functional domains of CaM and cTnC, we added SacI obtained by digesting pTnCPL3 with NcoI and SacI. The resulting and SalI sites to pCaMPL and a SalI site to pTnCPL3 in the cDNA protein product contains amino acid residues 1-56 of cTnC, 48-80 of sequences that correspond to the amino acid residues indicated in CaM, and 93-161 of cTnC. Fig. 1. These restriction sites enabled us toexchange domains 3 and pCaMfCH-TnCj-To construct this chimera, we used overlap ex- 4. For the central helix exchange, addition of restriction sites was tension PCR (17). In first stage PCR 1, pCaM[SacI] is the template, impractical because of objectionable mutations.Instead, we used the forward oligo is ACC ACA CCT ATG GTG TAT GC (oligo 3; lies overlap extension PCR (17). The details of construction are in the 70-bp 5’ to the NcoI site/initiation codons of pCaMPL and pTn- following paragraphs. CPL3), andthe reverse oligo is CCT TTG CTG TCA TCT pCaMf3,4 TnC], pTnCf3,4 CUM], and pTnCf3,4 CaMIfBMll- TTC ATT TTC CTG GCC ATC ATG GTC. In first stage PCR 2, The bacterial expression plasmid pTnCPL3 (chicken cTnC) (18, 19) pTnC[3,4 CaM] is the template, the forward oligo is G ACC ATG has a SocI site (GAG CTC). A SacI site was engineered into the ATG GCC AGGAAA ATG AAA GAT GACAG, and the reverse corresponding position of pCaMPL. This mutates Ile-85 of CaM oligo is oligo 2. The two first stage products are combined with oligos to Leu, which has no effect on Ca2+ binding or activation of the 2 and 3 in a second stage PCR. The second stage product is subcloned target enzymes presented here (data not shown). We call this as described for pCaM[2 TnC]. This construction yields a protein mutant pCaM[Saclj. TheSad-NdeI restriction fragments were product that is identical to CaM, except that residues 76-85 are then exchanged between pCaM[SacI] andpTnCPL3 to produce replaced by residues 85-97 of cTnC (see Fig. 1; the exchange runs Downloaded from pCaM[3,4 TnC]and pTnC[3,4 CaM]. To make pTnC[3,4 CaM] from the overlap extension splice point to the SacI site). [BMl], the NcoI-Sac1 fragment of pCBMl (18) was subcloned into pCaMf4 TnC] and pTnCf4 CaM]-Using overlap extension, a the corresponding site of pCaM[SacI]. unique Sal1 site was engineered between bp 364-370 of pCaM(Sac1) pCaMf2 TnC]-The expression plasmid pCaT encodes a CaM. and between bp 398 and 403 of pTnCPL3.
Recommended publications
  • Evidence for Rho Kinase Pathway
    Oncogene (2001) 20, 2112 ± 2121 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway Vanya Shah3, Shantaram Bharadwaj1,2, Kozo Kaibuchi4 and GL Prasad*,1,2 1Department of General Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, NC 27157, USA; 2Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, NC 27157, USA; 3Wistar Institute of Anatomy and Cell Biology, Philadelphia, Pennsylvania, USA; 4Nara Institute of Science and Technology Ikoma, Japan Tropomyosin (TM) family of cytoskeletal proteins is and tropomyosins (TMs) are suppressed to varying implicated in stabilizing actin micro®laments. Many TM degrees in many transformed cells (Ben-Ze'ev, 1997). isoforms, including tropomyosin-1 (TM1), are down- Furthermore, restoration of these proteins inhibits the regulated in transformed cells. Previously we demon- malignant phenotype of many dierent experimentally strated that TM1 is a suppressor of the malignant transformed cell lines, underscoring the pivotal role of transformation, and that TM1 reorganizes micro®la- cytoskeletal organization in maintaining a normal ments in the transformed cells. To investigate how TM1 phenotype (Ayscough, 1998; Janmey and Chaponnier, induces micro®lament organization in transformed cells, 1995). Our laboratory has been interested in under- we utilized ras-transformed NIH3T3 (DT) cells, and standing the role of cytoskeletal proteins, in particular those transduced to express TM1, and/or TM2. that of tropomyosins, in malignant transformation. Enhanced expression of TM1 alone, but not TM2, Tropomyosin (TM) family comprises of 5 ± 7 results in re-emergence of micro®laments; TM1, together dierent closely related isoforms, whose expression is with TM2 remarkably improves micro®lament architec- altered in many transformed cells (Lin et al., 1997; ture.
    [Show full text]
  • Calmodulin Dependent Wound Repair in Dictyostelium Cell Membrane
    cells Article Ca2+–Calmodulin Dependent Wound Repair in Dictyostelium Cell Membrane Md. Shahabe Uddin Talukder 1,2, Mst. Shaela Pervin 1,3, Md. Istiaq Obaidi Tanvir 1, Koushiro Fujimoto 1, Masahito Tanaka 1, Go Itoh 4 and Shigehiko Yumura 1,* 1 Graduate School of Sciences and Technology for Innovation, Yamaguchi University, Yamaguchi 753-8511, Japan; [email protected] (M.S.U.T.); [email protected] (M.S.P.); [email protected] (M.I.O.T.); [email protected] (K.F.); [email protected] (M.T.) 2 Institute of Food and Radiation Biology, AERE, Bangladesh Atomic Energy Commission, Savar, Dhaka 3787, Bangladesh 3 Rajshahi Diabetic Association General Hospital, Luxmipur, Jhautala, Rajshahi 6000, Bangladesh 4 Department of Molecular Medicine and Biochemistry, Akita University Graduate School of Medicine, Akita 010-8543, Japan; [email protected] * Correspondence: [email protected]; Tel./Fax: +81-83-933-5717 Received: 2 April 2020; Accepted: 21 April 2020; Published: 23 April 2020 Abstract: Wound repair of cell membrane is a vital physiological phenomenon. We examined wound repair in Dictyostelium cells by using a laserporation, which we recently invented. We examined the influx of fluorescent dyes from the external medium and monitored the cytosolic Ca2+ after wounding. The influx of Ca2+ through the wound pore was essential for wound repair. Annexin and ESCRT components accumulated at the wound site upon wounding as previously described in animal cells, but these were not essential for wound repair in Dictyostelium cells. We discovered that calmodulin accumulated at the wound site upon wounding, which was essential for wound repair.
    [Show full text]
  • Calmodulin: a Prototypical Calcium Sensor
    TCB 08/00 paste-up 30/6/00 8:54 am Page 322 reviews Calmodulin: a the Ca21 signal. Hence, separate intracellular loci or organelles are potentially distinct compartments of prototypical localized Ca21 signalling2 (Fig. 1a). Therefore, Ca21 signals in the nucleus exert different effects from those generated in the cytoplasm or near the plasma calcium sensor membrane of the same cell3. Additionally, the modulation of the amplitude or frequency of Ca21 spikes (AM and FM, respectively) encodes important David Chin and Anthony R. Means signalling information4. This has recently been illustrated for cases in which an optimal frequency of intracellular Ca21 oscillations is important for the Calmodulin is the best studied and prototypical example of the expression of different genes5. 21 E–F-hand family of Ca -sensing proteins. Changes in Calcium-regulated proteins: calmodulin 21 intracellular Ca21 concentration regulate calmodulin in three How do Ca signals produce changes in cell func- tion? The information encoded in transient Ca21 distinct ways. First, at the cellular level, by directing its signals is deciphered by various intracellular Ca21- binding proteins that convert the signals into a wide subcellular distribution. Second, at the molecular level, by variety of biochemical changes. Some of these 21 promoting different modes of association with many target proteins, such as protein kinase C, bind to Ca and are directly regulated in a Ca21-dependent manner. proteins. Third, by directing a variety of conformational states in Other Ca21-binding proteins, however, are inter- mediaries that couple the Ca21 signals to biochemical calmodulin that result in target-specific activation.
    [Show full text]
  • Calmodulin Binding Proteins and Alzheimer's Disease
    International Journal of Molecular Sciences Review Calmodulin Binding Proteins and Alzheimer’s Disease: Biomarkers, Regulatory Enzymes and Receptors That Are Regulated by Calmodulin Danton H. O’Day 1,2 1 Cell and Systems Biology, University of Toronto, Toronto, ON M5S 3G5, Canada; [email protected] 2 Department of Biology, University of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada Received: 18 September 2020; Accepted: 3 October 2020; Published: 5 October 2020 Abstract: The integral role of calmodulin in the amyloid pathway and neurofibrillary tangle formation in Alzheimer’s disease was first established leading to the “Calmodulin Hypothesis”. Continued research has extended our insight into the central function of the small calcium sensor and effector calmodulin and its target proteins in a multitude of other events associated with the onset and progression of this devastating neurodegenerative disease. Calmodulin’s involvement in the contrasting roles of calcium/CaM-dependent kinase II (CaMKII) and calcineurin (CaN) in long term potentiation and depression, respectively, and memory impairment and neurodegeneration are updated. The functions of the proposed neuronal biomarker neurogranin, a calmodulin binding protein also involved in long term potentiation and depression, is detailed. In addition, new discoveries into calmodulin’s role in regulating glutamate receptors (mGluR, NMDAR) are overviewed. The interplay between calmodulin and amyloid beta in the regulation of PMCA and ryanodine receptors are prime examples of how the buildup of classic biomarkers can underly the signs and symptoms of Alzheimer’s. The role of calmodulin in the function of stromal interaction molecule 2 (STIM2) and adenosine A2A receptor, two other proteins linked to neurodegenerative events, is discussed.
    [Show full text]
  • Calmodulin-Androgen Receptor (AR) Interaction: Calcium- Dependent, Calpain-Mediated Breakdown of AR in Lncapprostatecancer Cells
    Research Article Calmodulin-Androgen Receptor (AR) Interaction: Calcium- Dependent, Calpain-Mediated Breakdown of AR in LNCaPProstateCancer Cells Ronald P. Pelley,1 Kannagi Chinnakannu,1 Shalini Murthy,1 Faith M. Strickland,2 Mani Menon,1 Q. Ping Dou,3 Evelyn R. Barrack,1 and G. Prem-Veer Reddy1,3 1Vattikuti Urology Institute and 2Department of Dermatology, Henry Ford Hospital; 3Karmanos Cancer Institute and Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan Abstract Introduction Chemotherapy of prostate cancer targets androgen receptor Adenocarcinoma of the prostate is the most frequently (AR) by androgen ablation or antiandrogens, but unfortu- diagnosed cancer and second leading cause of cancer deaths in nately, it is not curative. Our attack on prostate cancer American men (1). Although androgen ablation is the most envisions the proteolytic elimination of AR, which requires a common therapy for disseminated prostate cancer, it is palliative fuller understanding of AR turnover. We showed previously in nature and most patients eventually succumb to hormone- that calmodulin (CaM) binds to AR with important con- refractory disease resistant to chemotherapy. Whether normal or sequences for AR stability and function. To examine the mutated, androgen receptor (AR) is required for growth in both involvement of Ca2+/CaM in the proteolytic breakdown of AR, androgen-sensitive and androgen-insensitive prostate cancer (2). we analyzed LNCaP cell extracts that bind to a CaM affinity Therefore, it is of paramount importance to dissect the various column for the presence of low molecular weight forms of AR ways in which AR is regulated to not simply inactivate but to (intact AR size, f114 kDa).
    [Show full text]
  • Synaptotagmin 7 Functions As a Ca2+-Sensor for Synaptic Vesicle Replenishment
    IN PRESS Synaptotagmin 7 Functions as a Ca2+-sensor for Synaptic Vesicle Replenishment Huisheng Liu (University of Wisconsin), Hua Bai (University of Wisconsin), Enfu Hui (University of Wisconsin), Lu Yang (University of Wisconsin), Chantell Evans (University of Wisconsin), Zhao Wang (University of Wisconsin), Sung Kwon (University of Wisconsin), and Edwin Chapman (University of Wisconsin) Abstract: Synaptotagmin (syt) 7 is one of three syt isoforms found in all metazoans; it is ubiquitously expressed, yet its function in neurons remains obscure. Here, we resolved Ca2+-dependent and Ca2+-independent synaptic vesicle (SV) replenishment pathways, and found that syt 7 plays a selective and critical role in the Ca2+-dependent pathway. Mutations that disrupt Ca2+-binding to syt 7 abolish this function, suggesting that syt 7 functions as a Ca2+-sensor for replenishment. The Ca2+-binding protein calmodulin (CaM) has also been implicated in SV replenishment, and we found that loss of syt 7 was phenocopied by a CaM antagonist. Moreover, we discovered that syt 7 binds to CaM in a highly specific and Ca2+-dependent manner; this interaction requires intact Ca2+-binding sites within syt 7. Together, these data indicate that a complex of two conserved Ca2+-binding proteins, syt 7 and CaM, serve as a key regulator of SV replenishment in presynaptic nerve terminals. http://dx.doi.org/10.7554/elife.01524 Please address questions to [email protected]. Details on how to cite eLife articles in news stories and our media policy are available at http://www.elifesciences.org/news/for-the- press. Articles published in eLife may be read on the journal site at http://elife.elifesciences.org.
    [Show full text]
  • The Interactome and Spatial Redistribution Feature of Ca2+ Receptor Protein Calmodulin Reveals a Novel Role in Invadopodia- Mediated Invasion
    Li et al. Cell Death and Disease (2018) 9:292 DOI 10.1038/s41419-017-0253-7 Cell Death & Disease ARTICLE Open Access The interactome and spatial redistribution feature of Ca2+ receptor protein calmodulin reveals a novel role in invadopodia- mediated invasion Tao Li1,2,3,4,LiYi1,2,LongHai1,2,HaiwenMa1,2,ZhennanTao1,2, Chen Zhang5, Iruni Roshanie Abeysekera1,6,KaiZhao7, Yihan Yang1,2,WeiWang1,2,BoLiu1,2, Shengping Yu1,2,LuqingTong1,2, Peidong Liu1,2,MengZhu8, Bingcheng Ren1,2, Yu Lin1,2, Kai Zhang1,2, Cheng Cheng1,2, Yubao Huang1,2 and Xuejun Yang1,2 Abstract Numerous studies have shown that calmodulin (CaM) is a major regulator of calcium-dependent signaling, which regulates cell proliferation, programmed cell death, and autophagy in cancer. However, limited information is available on mechanisms underlying the effect of CaM on the invasive property of glioblastoma multiforme (GBM) cells, especially with respect to invadopodia formation. In this study, we find that CaM serves as a prognostic factor for GBM, and it is strongly associated with the invasive nature of this tumor. Results of preliminary experiments indicated that CaM concentration was significantly correlated with the invasive capacity of and invadopodia formation by different GBM cell lines. CaM inhibition via a small hairpin RNA or a pharmacological inhibitor significantly disrupted invadopodia formation and MMP activity and downregulated vimentin expression. Moreover, CaM knockdown 1234567890():,; 1234567890():,; exerted a strong anti-invasive effect on GBM in vivo. Interestingly, epidermal growth factor treatment promoted CaM redistribution from the nucleus to the cytoplasm, eventually activating invadopodia-associated proteins by binding to them via their cytosolic-binding sites.
    [Show full text]
  • Conformational Changes of Calmodulin Upon Ca Binding
    Conformational changes of calmodulin upon Ca2؉ binding studied with a microfluidic mixer Hye Yoon Park*, Sally A. Kim*†, Jonas Korlach*‡, Elizabeth Rhoades*§, Lisa W. Kwok*¶, Warren R. Zipfelʈ, M. Neal Waxham**, Watt W. Webb*††, and Lois Pollack*†† *School of Applied and Engineering Physics and ʈDepartment of Biomedical Engineering, Cornell University, Ithaca, NY 14853; and **Department of Neurobiology and Anatomy, University of Texas Health Science Center, Houston, TX 77030 Contributed by Watt W. Webb, November 14, 2007 (sent for review October 12, 2007) A microfluidic mixer is applied to study the kinetics of calmodulin A faster response is desirable for reporting rapid events such as .(conformational changes upon Ca2؉ binding. The device facilitates neuronal Ca2ϩ dynamics (9 rapid, uniform mixing by decoupling hydrodynamic focusing from Here, we describe the kinetics of Ca2ϩ-induced structural diffusive mixing and accesses time scales of tens of microseconds. changes of CaM using a microfluidic implementation of rapid The mixer is used in conjunction with multiphoton microscopy to mixing. We developed and characterized a microfluidic mixer examine the fast Ca2؉-induced transitions of acrylodan-labeled capable of microsecond-scale kinetic experiments (10). The calmodulin. We find that the kinetic rates of the conformational five-inlet port device effectively reduces premixing present in changes in two homologous globular domains differ by more than previous hydrodynamic focusing mixers (11) and facilitates an order of magnitude. The characteristic time constants are Ϸ490 rapid, uniform mixing. We demonstrate the first application of ␮s for the transitions in the C-terminal domain and Ϸ20 ms for this technology to studying protein conformational changes on a those in the N-terminal domain of the protein.
    [Show full text]
  • Calmodulin and Its Binding Proteins in Parkinson's Disease
    International Journal of Molecular Sciences Review Calmodulin and Its Binding Proteins in Parkinson’s Disease Anastasiia Bohush 1, Wiesława Le´sniak 1, Serge Weis 2 and Anna Filipek 1,* 1 Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland; [email protected] (A.B.); [email protected] (W.L.) 2 Division of Neuropathology, Department of Pathology and Molecular Pathology, Neuromed Campus, Kepler University Hospital, Johannes Kepler University, A-4020 Linz, Austria; [email protected] * Correspondence: a.fi[email protected] Abstract: Parkinson’s disease (PD) is a neurodegenerative disorder that manifests with rest tremor, muscle rigidity and movement disturbances. At the microscopic level it is characterized by formation of specific intraneuronal inclusions, called Lewy bodies (LBs), and by a progressive loss of dopamin- ergic neurons in the striatum and substantia nigra. All living cells, among them neurons, rely on Ca2+ as a universal carrier of extracellular and intracellular signals that can initiate and control various cellular processes. Disturbances in Ca2+ homeostasis and dysfunction of Ca2+ signaling pathways may have serious consequences on cells and even result in cell death. Dopaminergic neurons are particularly sensitive to any changes in intracellular Ca2+ level. The best known and studied Ca2+ sensor in eukaryotic cells is calmodulin. Calmodulin binds Ca2+ with high affinity and regulates the activity of a plethora of proteins. In the brain, calmodulin and its binding proteins play a crucial role in regulation of the activity of synaptic proteins and in the maintenance of neuronal plasticity. Thus, any changes in activity of these proteins might be linked to the development and progression of neurodegenerative disorders including PD.
    [Show full text]
  • Mathematical Modeling of the Calcium Binding Proteins Calmodulin and Troponin C
    Mathematical Modeling of the Calcium Binding Proteins Calmodulin and Troponin C Undergraduate Research Thesis Presented in partial fulfillment of the requirements for graduation with honors research distinction in the undergraduate colleges of The Ohio State University by Garrett Hauck The Ohio State University 2021 Project Advisor: Professor Jonathan Davis, Department of Physiology and Cell Biology Abstract Cellular calcium either directly controls, or at a minimum modulates nearly, if not, all human functions. As such, the structural motif that forms the calcium binding pocket (EF-hand) is one of the most common protein elements found in Mammalia. The calcium binding properties of the EF-hands appear to be “tuned” to receive and respond to different calcium signals and can vary by over 6 orders of magnitude. Our laboratory is attempting to understand the rules that govern calcium binding to proteins, so that we might be able to engineer these proteins as gene therapies to treat diseases. Calmodulin is a small, switch-like, calcium binding protein that plays multiple roles in all human cells depending on what protein system it is attached. We are using rational design, super computers as well as evolutionary clues to help us engineer calmodulins with specific functionalities. Using a simple mathematical model to describe the calcium binding events of calmodulin and available steady-state and kinetic data, we determined the exact rate parameters that govern this interaction for wild type calmodulin and other variants (such as plant calmodulins, disease mutants, and engineered calmodulins). Troponin C is the “cousin” of calmodulin and is very important in the calcium regulation of muscle contraction.
    [Show full text]
  • Chapter 4 Calsequestrin
    Chapter 4 Calsequestrin DAVID H. MacLENNAN Banting and Best Department of Medical Research C. H. Best Institute, University of Toronto Toronto, Ontario, Canada KEVIN P. CAMPBELL Department of Physiology and Biophysics University of Iowa Iowa City, Iowa and REINHART A. F. REITHMEIER Department of Biochemistry University of Alberta Edmonton, Alberta, Canada I. Sarcoplasmic Reticulum ............................................................................. 152 II. Isolated Sarcoplasmic Reticulum Vesicles ................................................. 153 III. Isolation of Calsequestrin ........................................................................... 155 IV. Ca2+ Binding by Calsequestrin ................................................................... 155 V. Size and Shape of Calsequestrin................................................................. 157 VI. Amino Acid Sequence................................................................................ 159 VII. Carbohydrate Content................................................................................. 160 VIII. Stains-All Staining...................................................................................... 160 IX. Properties of Calsequestrin in Other Muscles............................................. 161 X. Phosphorylation of Calsequestrin ............................................................... 162 XI. Localization of Calsequestrin ..................................................................... 163 XII. Biosynthesis...............................................................................................
    [Show full text]
  • Contribution of Calpains to Myocardial Ischaemia/Reperfusion Injury
    Cardiovascular Research (2012) 96,23–31 SPOTLIGHT REVIEW doi:10.1093/cvr/cvs232 Contribution of calpains to myocardial ischaemia/reperfusion injury Javier Inserte*, Victor Hernando, and David Garcia-Dorado Laboratory of Experimental Cardiology, Department of Cardiology, Vall d’Hebron University Hospital and Research Institute, Universitat Auto`noma de Barcelona, Barcelona, Spain Downloaded from https://academic.oup.com/cardiovascres/article/96/1/23/540293 by guest on 28 September 2021 Received 10 May 2012; revised 3 July 2012; accepted 6 July 2012; online publish-ahead-of-print 10 July 2012 + Abstract Loss of calcium (Ca2 ) homeostasis contributes through different mechanisms to cell death occurring during the first + minutes of reperfusion. One of them is an unregulated activation of a variety of Ca2 -dependent enzymes, including the non-lysosomal cysteine proteases known as calpains. This review analyses the involvement of the calpain family in reperfusion-induced cardiomyocyte death. Calpains remain inactive before reperfusion due to the acidic pHi and increased ionic strength in the ischaemic myocardium. However, inappropriate calpain activation occurs during myo- cardial reperfusion, and subsequent proteolysis of a wide variety of proteins contributes to the development of con- tractile dysfunction and necrotic cell death by different mechanisms, including increased membrane fragility, further + + impairment of Na and Ca2 handling, and mitochondrial dysfunction. Recent studies demonstrating that calpain in- hibition contributes to
    [Show full text]